A detailed history of Dimensional Fund Advisors LP transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,748,663 shares of RLAY stock, worth $8.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,748,663
Previous 1,520,340 15.02%
Holding current value
$8.94 Million
Previous $9.91 Million 24.9%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$6.23 - $9.51 $1.42 Million - $2.17 Million
228,323 Added 15.02%
1,748,663 $12.4 Million
Q2 2024

Aug 09, 2024

SELL
$5.9 - $8.02 $474,796 - $645,401
-80,474 Reduced 5.03%
1,520,340 $9.91 Million
Q1 2024

May 10, 2024

BUY
$7.5 - $12.07 $1.81 Million - $2.92 Million
241,659 Added 17.78%
1,600,814 $13.3 Million
Q4 2023

Feb 07, 2024

BUY
$6.01 - $11.48 $2.05 Million - $3.92 Million
341,487 Added 33.56%
1,359,155 $15 Million
Q3 2023

Nov 09, 2023

SELL
$8.24 - $12.97 $1.21 Million - $1.9 Million
-146,718 Reduced 12.6%
1,017,668 $8.56 Million
Q2 2023

Aug 09, 2023

SELL
$9.99 - $18.27 $713,375 - $1.3 Million
-71,409 Reduced 5.78%
1,164,386 $14.6 Million
Q1 2023

May 12, 2023

BUY
$15.0 - $22.76 $2.66 Million - $4.03 Million
177,252 Added 16.74%
1,235,795 $20.4 Million
Q4 2022

Feb 09, 2023

BUY
$14.16 - $24.02 $5.99 Million - $10.2 Million
422,936 Added 66.54%
1,058,543 $15.8 Million
Q3 2022

Nov 10, 2022

BUY
$18.07 - $31.37 $4.37 Million - $7.59 Million
241,816 Added 61.41%
635,607 $14.2 Million
Q2 2022

Aug 12, 2022

BUY
$13.31 - $34.88 $4.47 Million - $11.7 Million
335,925 Added 580.52%
393,791 $6.6 Million
Q1 2022

May 13, 2022

BUY
$20.26 - $32.36 $1.17 Million - $1.87 Million
57,866 New
57,866 $1.73 Million
Q3 2021

Nov 12, 2021

SELL
$29.75 - $37.99 $185,521 - $236,905
-6,236 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$32.52 - $61.53 $202,794 - $383,701
6,236 New
6,236 $216,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $614M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.